Ecolab Inc.
ECLBasic MaterialsNASDAQSpecialty Chemicals
Scan Results
Daily timeframeEcolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. At a $77.96B market cap, Ecolab Inc. ranks as a large-cap company within basic materials. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences.
Market Cap
$77.96B
Beta
0.89
P/E (TTM)
37.28
P/E (Fwd)
29.53
EPS (TTM)
$7.46
EPS (Fwd)
$9.42
ROE
22.0%
ROA
7.2%
Cash
$5.14B
Total Debt
$13.92B
Free CF
$1.47B
52W Change
3.8%
Annual Financials
Cash vs Debt
Where ECL stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, ECL finished 2.30% above its 150-day moving average ($273.60) and 3.01% above its 200-day moving average ($271.73). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ECL overbought or oversold?
At the September 3, 2026 close, ECL's RSI(14) was 55.1, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, ECL has $5.14B in cash with $13.92B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $1.47B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 22.0% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $14.19B to $16.08B.
As with any equity investment, ECL carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ECL.